We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.135 | 0.13 | 0.14 | 0.135 | 0.135 | 0.14 | 104,139 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 2.48M | -1.15M | -0.0006 | -2.17 | 2.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/2/2017 20:16 | Ramnik, I suspect any good news will come with the RNS regarding the 2016 full year accounts. | bigt20 | |
17/2/2017 17:19 | ....desperately need an RNS that helps bottom line immediately. | ramnik007 | |
17/2/2017 09:04 | Someone seems to think 4p is a good investment, but we need to get out of this range we've been stuck in for too long, good RNS might help... | gbenson1 | |
10/2/2017 17:26 | Well the net result of the buying and selling at historic lows has been nothing for the last few days, so for every seller who has got bored, a buyer thinks its near the bottom. At the moment it seems to be a firmish bottom, rather than a wobbly one, so the interpretation could be mildly positive. At some point, if there is no more bad news for a share, the continual drops stop. Then it takes a while for the buying to outweigh the selling. Back in August/September there was more positive news on US, which appears to have caused a small spike, but the effect of that and the UK on the figures was unknown. Now things are a little more certain and the actual business problems caused by the UK falling, look likely to stabilise. Its possible the previous bad news and problems are all in the price at last and now its just a question of waiting for the results to show revenue starting to grow. I hope so as got quite a few around 4p now, on the basis that I think any tangible improvement will cause a rapid share price rise which will not come back down again. Fingers and other stuff crossed ! | yump | |
10/2/2017 13:15 | It's not a good sign when investors are selling at near historic lows, they've either finally lost patience or don't see any upside, alternatively it might be someone keeping the share price artificially low to get an entry point, trying not to get emotionally attached to a stock..... | gbenson1 | |
06/2/2017 14:18 | BigT20, thinks it's been broadly discussed on here UK sales (NHS) is a difficult organisation to crack , I'm not holding my breath for increase in UK income, thinks its US and ROW. All buying is good buying!! imho. | gbenson1 | |
06/2/2017 14:07 | gbenson16 Feb '17 - 11:35 - 8613 of 8615 0 0 ........., break even will come sooner rather than later, --> depends on whether the UK sales stabilise and non US growth (as we know the US is growing). | bigt20 | |
06/2/2017 13:50 | If I was a betting man, looks like someone's trying to get the Sp down before a chunky buy?? | gbenson1 | |
06/2/2017 11:35 | A rise in the share price would be nice, break even will come sooner rather than later, we need to be pushing PR and sales more in the US to get on the radar, someone is building a stake? | gbenson1 | |
06/2/2017 11:25 | I predict a takeover will come as soon as they pass break even !!!! | parsons4 | |
06/2/2017 10:11 | Nice few buys this morning, expecting positive RNS soon.. | gbenson1 | |
02/2/2017 09:24 | ...and another one from Oscar Wilde: I have nothing to declare but my Guinness. | arf dysg | |
01/2/2017 22:09 | Still a good buying opportunity!! | waywardlad | |
01/2/2017 17:41 | We may be lying in the gutter, but we are looking at the stars. | arf dysg | |
01/2/2017 12:09 | Dont speak too soon, but DM up a smidge on low volume, things are looking up... | gbenson1 | |
30/1/2017 18:52 | You can count on it. | arf dysg | |
30/1/2017 17:25 | Is The Count still in these? | youwontripmeoffagain | |
27/1/2017 08:49 | Ask Hadrian! | bigt20 | |
26/1/2017 21:51 | Just out of curiosity, does anyone know how much of Hadrian's Wall remains ? | yump | |
26/1/2017 17:45 | The second one is probably true, and I SOOOOOOOOOOO want the first one to be true. Irony indeed, and it might even be true. | arf dysg | |
25/1/2017 14:35 | Science always wins in the end, because it doesn't change. The law of gravity doesn't change, so it survives the constantly-changing collection of stories which try to explain why those funny lights move in the night sky, and why we have winter and summer. However... it may take hundreds of years for superstition, fear and vested interests to grow old and die. | arf dysg | |
25/1/2017 13:43 | "Just shows what money loaded marketing and established sales channels do achieve." Especially in a country where there is a significant denial of scientific fact and empirical evidence, as a result of insidious doctrine in various forms, which if it was reported in one of our schools, would result in a visit from social services. ;-) or :-(( depending on your view. | yump | |
25/1/2017 12:29 | parsons425 Jan '17 - 07:28 - 8590 of 8598 Despite the good news from South Korea and good growth in the USA, I think we are still short of breakeven (cash wise). It would help alot if the sales in the UK stabilised too. | bigt20 | |
25/1/2017 12:04 | Interesting to note that Edwards claims that 3rd party market research indicates that the US Heamodynamic Monitoring market is worth $400M. Lets hope the US accounts start to gain traction for Deltex to take a slice of that pie. It is amazing that Edwards continues to sell tech in that market with very little scientific evidence. Just shows what money loaded marketing and established sales channels do achieve. They even use the the slide from UCL which was informed (I think) by the work done with Deltex. | ramnik007 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions